News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
883,740 Results
Type
Article (88772)
Company Profile (816)
Press Release (794130)
Multimedia
Podcasts (238)
Webinars (35)
Section
Business (233588)
Career Advice (4162)
Deals (39987)
Drug Delivery (177)
Drug Development (91701)
Employer Resources (207)
FDA (18553)
Job Trends (17486)
News (398725)
Policy (40013)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3053)
Academic (2)
Accelerated approval (56)
ADA (49)
Adcomms (40)
Allergies (195)
Alliances (56990)
ALS (236)
Alzheimer's disease (1967)
Antibody-drug conjugate (ADC) (551)
Approvals (18892)
Artificial intelligence (867)
ASCO (345)
Autoimmune disease (360)
Automation (64)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (248)
Biotechnology (480)
Bladder cancer (211)
Brain cancer (85)
Breast cancer (837)
Cancer (6560)
Cardiovascular disease (554)
Career advice (3597)
Career pathing (52)
CAR-T (384)
CDC (76)
Celiac Disease (3)
Cell therapy (1068)
Cervical cancer (54)
Clinical research (78979)
Collaboration (2365)
Company closure (8)
Compensation (1508)
Complete response letters (106)
COVID-19 (3041)
CRISPR (124)
C-suite (1282)
Cystic fibrosis (167)
Data (8661)
Decentralized trials (3)
Denatured (91)
Depression (193)
Dermatology (96)
Diabetes (703)
Diagnostics (7595)
Digital health (69)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (424)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (318)
Earnings (102482)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138629)
Executive appointments (1191)
FDA (22615)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (19)
Frontotemporal dementia (36)
Funding (1935)
Gene editing (270)
Generative AI (89)
Gene therapy (848)
GLP-1 (1284)
Government (5559)
Grass and pollen (8)
Guidances (419)
Healthcare (21259)
Hematology (198)
HIV (94)
Huntington's disease (64)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (352)
Immuno-oncology (115)
Indications (206)
Infectious disease (3438)
Inflammatory bowel disease (242)
Inflation Reduction Act (17)
Influenza (148)
Intellectual property (322)
Interviews (821)
IPO (18001)
IRA (61)
Job creations (5209)
Job search strategy (2871)
JPM (73)
Kidney cancer (23)
Labor market (122)
Layoffs (686)
Leadership (53)
Legal (10171)
Liver cancer (111)
Longevity (37)
Lung cancer (873)
Lymphoma (464)
Machine learning (66)
Management (66)
Manufacturing (1219)
MASH (226)
Medical device (15276)
Medtech (15433)
Mergers & acquisitions (23284)
Metabolic disorders (1820)
mRNA (266)
Multiple sclerosis (204)
NASH (24)
Neurodegenerative disease (506)
Neuropsychiatric disorders (126)
Neuroscience (3710)
Neurotech (2)
NextGen: Class of 2026 (7715)
Non-profit (5145)
Now hiring (80)
Obesity (869)
Opinion (374)
Ovarian cancer (244)
Pain (283)
Pancreatic cancer (349)
Parkinson's disease (415)
Partnered (39)
Patents (653)
Patient recruitment (755)
Peanut (70)
People (67989)
Pharmaceutical (136)
Pharmacy benefit managers (37)
Phase 1 (24407)
Phase 2 (34305)
Phase 3 (25799)
Pipeline (9717)
Policy (397)
Postmarket research (3559)
Preclinical (10978)
Press Release (72)
Prostate cancer (346)
Psychedelics (68)
Radiopharmaceuticals (372)
Rare diseases (1261)
Real estate (7462)
Recruiting (81)
Regulatory (30377)
Reports (77)
Research institute (2771)
Resumes & cover letters (654)
Rett syndrome (42)
RNA editing (29)
RSV (98)
Schizophrenia (196)
Series A (326)
Series B (236)
Service/supplier (28)
Sickle cell disease (127)
Special edition (32)
Spinal muscular atrophy (190)
Sponsored (55)
Startups (4371)
State (2)
Stomach cancer (21)
Supply chain (146)
Tariffs (104)
The Weekly (144)
Vaccines (1306)
Venture capital (133)
Weight loss (597)
Women's health (140)
Worklife (24)
Date
Today (113)
Last 7 days (657)
Last 30 days (3335)
Last 365 days (33288)
2026 (16103)
2025 (33218)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (402)
Arkansas (16)
Asia (52287)
Australia (9191)
California (14357)
Canada (4009)
China (1569)
Colorado (618)
Connecticut (639)
Delaware (443)
Europe (120583)
Florida (2129)
Georgia (467)
Hawaii (4)
Idaho (70)
Illinois (1248)
India (102)
Indiana (663)
Iowa (25)
Japan (589)
Kansas (143)
Kentucky (56)
Louisiana (64)
Maine (89)
Maryland (1740)
Massachusetts (10502)
Michigan (422)
Minnesota (799)
Mississippi (7)
Missouri (164)
Montana (37)
Nebraska (30)
Nevada (153)
New Hampshire (92)
New Jersey (3806)
New Mexico (35)
New York (3772)
North Carolina (1937)
North Dakota (11)
Northern California (7137)
Ohio (449)
Oklahoma (27)
Oregon (55)
Pennsylvania (2829)
Puerto Rico (30)
Rhode Island (54)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5631)
Tennessee (227)
Texas (2339)
United States (51365)
Utah (426)
Vermont (1)
Virginia (363)
Washington D.C. (89)
Washington State (1179)
West Virginia (4)
Wisconsin (160)
Wyoming (2)
There are 883,740 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IMAAVY® (nipocalimab-aahu) demonstrates durable hemoglobin response and rapid onset of effect in pivotal Phase 2/3 study in warm autoimmune hemolytic anemia (wAIHA), an autoantibody-driven disease with no FDA-approved therapies
June 11, 2026
·
16 min read
Press Releases
BioInvent’s TNFR2 Antibody BI-1808 Delivers Meaningful Responses and Immune Activation as Single Agent and in Combination with KEYTRUDA(R) (pembrolizumab) in Advanced CTCL (EHA 2026)
June 11, 2026
·
10 min read
Press Releases
BioInvent’s BI-1206 Triplet Achieves 83% Response Rate in Refractory NHL with Improved Safety vs. SOC (EHA 2026)
June 11, 2026
·
7 min read
Press Releases
Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia
June 11, 2026
·
5 min read
Insights
Portugal, Spain and the new biotech frontier
In this episode of Denatured, you’ll be hearing from Hannah Franklin, associate at Biovance Capital and Pablo Gabriel Cironi Lopez, director of life science investment at Caixa Capital Risc as they discuss the rise of Southern Europe’s biotech ecosystem.
June 11, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Job Trends
The wait continues: pressure to operate lean among factors behind slow job market
Just 23% of respondents to a
BioSpace
LinkedIn poll expect the biopharma job market will rebound in 2026. Three experts discuss when they see a turnaround happening and how increasing emphasis on cost efficiency is impacting hiring practices.
June 11, 2026
·
4 min read
·
Angela Gabriel
Job Trends
May layoffs hit nearly 7,000, with most cuts from Takeda, BioNTech
For the second time in 2026, the number of biopharma professionals affected by made or projected workforce reductions rose year over year. In May, layoffs spiked nearly 50%, mainly due to Takeda and BioNTech axing a combined 6,360 employees.
June 11, 2026
·
3 min read
·
Angela Gabriel
Press Releases
Cantargia and H.C. Wainwright to Host KOL Call on The Case for Nadunolimab in PDAC
June 11, 2026
·
3 min read
Press Releases
FDA Grants Priority Review for Genentech’s Tecentriq for a Certain Type of Stage III Colon Cancer
June 11, 2026
·
14 min read
Press Releases
Curatis Increases Revenue Growth Guidance for 2026
June 11, 2026
·
2 min read
1 of 88,374
Next
